Biomea Fusion (BMEA) Common Equity (2020 - 2026)

Biomea Fusion has reported Common Equity for 7 years, with the latest figure at $18.7 million in Q1 2026.

• Quarterly Common Equity fell 34.86% year-over-year to $18.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.7 million (down 34.86% YoY) and the FY2025 annual result came in at $29.6 million, down 42.7% from the prior year.
• Common Equity eased to $18.7 million in Q1 2026 per BMEA's latest filing, from $29.6 million in the prior quarter.
• Over five years, Common Equity peaked at $224.3 million in Q2 2023 and troughed at $15.6 million in Q3 2025.
• A 5-year average of $101.0 million and a median of $103.9 million in 2024 frame the typical range for Common Equity.
• The sharpest annual moves came in 2022 and 2025: Common Equity jumped 74454.3% in 2022, then tumbled 79.44% in 2025.
• Over 5 years, Common Equity stood at $108.5 million in 2022, then surged by 55.92% to $169.2 million in 2023, then slumped by 69.53% to $51.6 million in 2024, then plunged by 42.7% to $29.6 million in 2025, then tumbled by 36.66% to $18.7 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $18.7 million, $29.6 million, and $15.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.